BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Fernández-Yunquera A, Ripoll C, Bañares R, Puerto M, Rincón D, Yepes I, Catalina V, Salcedo M. Everolimus immunosuppression reduces the serum expression of fibrosis markers in liver transplant recipients. World J Transplant 2014; 4(2): 133-140 [PMID: 25032102 DOI: 10.5500/wjt.v4.i2.133]
URL: https://www.wjgnet.com/2220-3230/full/v4/i2/133.htm
Number Citing Articles
1
T. Nakamura, H. Ushigome, T. Takata, T. Nakao, S. Harada, K. Koshino, T. Suzuki, T. Ito, S. Nobori, N. Yoshimura. Histopathologic Impacts of Everolimus Introduction on Kidney Transplant RecipientsTransplantation Proceedings 2015; 47(3): 630 doi: 10.1016/j.transproceed.2014.09.180
2
Yangbao Xiao, Lei Zhou, Tongtong Zhang, Caicheng Qin, Peng Wei, Li Luo, Linzi Luo, Guojun Huang, Anji Chen, Guangnan Liu. Anti-fibrosis activity of quercetin attenuates rabbit tracheal stenosis via the TGF-β/AKT/mTOR signaling pathwayLife Sciences 2020; 250: 117552 doi: 10.1016/j.lfs.2020.117552
3
Maria Morgan-Bathke, Zoey I. Harris, Deborah G. Arnett, Rob R. Klein, Randy Burd, David K. Ann, Kirsten H. Limesand, John A. Chiorini. The Rapalogue, CCI-779, Improves Salivary Gland Function following RadiationPLoS ONE 2014; 9(12): e113183 doi: 10.1371/journal.pone.0113183
4
Roberta Angelico, Giuseppe Iaria, Mario Angelico. Kidney Transplantation, Bioengineering and Regeneration2017; : 653 doi: 10.1016/B978-0-12-801734-0.00046-1
5
A. Frey, E.-M. Ecker, K. Piras-Straub, A. Walker, T.G. Hofmann, J. Timm, B.B. Singer, G. Gerken, K. Herzer. Effects of the Mammalian Target of Rapamycin Inhibitor Everolimus on Hepatitis C Virus Replication In Vitro and In VivoTransplantation Proceedings 2017; 49(8): 1947 doi: 10.1016/j.transproceed.2017.04.012
6
Emily A. Saunders, Bastian Engel, Anne Höfer, Björn Hartleben, Florian W.R. Vondran, Nicolas Richter, Andrej Potthoff, Steffen Zender, Heiner Wedemeyer, Elmar Jaeckel, Richard Taubert. Outcome and safety of a surveillance biopsy guided personalized immunosuppression program after liver transplantationAmerican Journal of Transplantation 2022; 22(2): 519 doi: 10.1111/ajt.16817
7
Manuela G. Neuman, Lawrence B. Cohen, Radu M. Nanau. Hyaluronic acid as a non-invasive biomarker of liver fibrosisClinical Biochemistry 2016; 49(3): 302 doi: 10.1016/j.clinbiochem.2015.07.019
8
Emily A. Bosselmann, Fabian Dranicki, Alejandro Campos-Murguia, Björn Hartleben, Heiner Wedemeyer, Elmar Jaeckel, Richard Taubert. Combination of everolimus and low-dose tacrolimus controls histological liver allograft injury as sufficiently as high-dose tacrolimusFrontiers in Transplantation 2023; 2 doi: 10.3389/frtra.2023.1168163
9
Emily A. Bosselmann, Bastian Engel, Björn Hartleben, Heiner Wedemeyer, Elmar Jaeckel, Benjamin Maasoumy, Andrej Potthoff, Steffen Zender, Richard Taubert. Prospective comparison of liver stiffness measurement methods in surveillance biopsies after liver transplantationFrontiers in Transplantation 2023; 2 doi: 10.3389/frtra.2023.1148195
10
Rong-Jane Chen, Hsiang-Hua Wu, Ying-Jan Wang. Strategies to prevent and reverse liver fibrosis in humans and laboratory animalsArchives of Toxicology 2015; 89(10): 1727 doi: 10.1007/s00204-015-1525-6
11
Jian-Gang Sun, Peng Nie, Piet Herdewijn, Xiao-Jing Li. Exploring the synthetic approaches and clinical prowess of established macrocyclic pharmaceuticalsEuropean Journal of Medicinal Chemistry 2024; 264: 116051 doi: 10.1016/j.ejmech.2023.116051
12
Katharina Beuke, Frank A. Schildberg, Federico Pinna, Ute Albrecht, Roman Liebe, Michaela Bissinger, Peter Schirmacher, Steven Dooley, Johannes G. Bode, Percy A. Knolle, Ursula Kummer, Kai Breuhahn, Sven Sahle. Quantitative and integrative analysis of paracrine hepatocyte activation by nonparenchymal cells upon lipopolysaccharide inductionThe FEBS Journal 2017; 284(5): 796 doi: 10.1111/febs.14022
13
Rivada Kurabekova, Olga Tsirulnikova, Irina Pashkova, Olga Gichkun, Natalia Mozheyko, Sergey Gautier, Olga Shevchenko. Transforming growth factor beta 1 levels in the blood of pediatric liver recipients: Clinical and biochemical correlationsPediatric Transplantation 2020; 24(3) doi: 10.1111/petr.13693
14
Bastian Engel, Ida Falk Villesen, Mette Juul Fisker Nielsen, Morten Karsdal, Richard Taubert, Elmar Jaeckel, Diana Julie Leeming. Quantification of extracellular matrix remodeling for the non-invasive identification of graft fibrosis after liver transplantationScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-33100-7
15
Itxarone Bilbao, Magdalena Salcedo, Miguel Angel Gómez, Carlos Jimenez, Javier Castroagudín, Joan Fabregat, Carolina Almohalla, Ignacio Herrero, Valentín Cuervas‐Mons, Alejandra Otero, Angel Rubín, Manuel Miras, Juan Rodrigo, Trinidad Serrano, Gonzalo Crespo, Manuel De la Mata, Javier Bustamante, M. Luisa Gonzalez‐Dieguez, Antonia Moreno, Isidoro Narvaez, Magda Guilera. Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in SpainLiver Transplantation 2015; 21(8): 1056 doi: 10.1002/lt.24172
16
Tiziana Vinciguerra, Andrea Brunati, Ezio David, Filomena Longo, Michele Pinon, Fulvio Ricceri, Luisa Castellino, Antonio Piga, Maria Teresa Giraudo, Francesco Tandoi, Fabio Cisarò, Dominic Dell Olio, Giuseppe Isolato, Renato Romagnoli, Mauro Salizzoni, Pier Luigi Calvo. Transient elastography for non‐invasive evaluation of post‐transplant liver graft fibrosis in childrenPediatric Transplantation 2018; 22(2) doi: 10.1111/petr.13125
17
R. M. Kurabekova, O. P. Shevchenko, O. M. Tsiroulnikova. TRANSFORMING GROWTH FACTOR 1 AT LIVER TRANSPLANTATIONRussian Journal of Transplantology and Artificial Organs 2015; 17(3): 76 doi: 10.15825/1995-1191-2015-3-76-82